about
Huperzine A for mild cognitive impairmentSulodexide for treating venous leg ulcersMalnutrition-sarcopenia syndrome predicts mortality in hospitalized older patientsPredicting long-term mortality in hospitalized elderly patients using the new ESPEN definition.The Klotho gene G-395A polymorphism and metabolic syndrome in very elderly peopleG-395A polymorphism in the promoter region of the KLOTHO gene associates with reduced cognitive impairment among the oldest old.Association between sleep duration and sarcopenia among community-dwelling older adults: A cross-sectional study.Sarcopenia predicts readmission and mortality in elderly patients in acute care wards: a prospective study.Content comparison of self-reported disability measures for the elderly according to the international classification of functioning, disability and health.The measurement of disability in the elderly: a systematic review of self-reported questionnaires.Prevalence of Sarcopenia and Associated Factors in Chinese Community-Dwelling Elderly: Comparison Between Rural and Urban Areas.Systemic antifungal therapy for tinea capitis in children: An abridged Cochrane Review.Does residing in urban or rural areas affect the incidence of polypharmacy among older adults in western China?The association of falls and various physical activities in Chinese nonagenarians/centenarians.G-395A polymorphism in the promoter region of the KLOTHO gene and hypertension among elderly (90 years and older) Chinese individuals.Association between waist circumference and self-reported disability among Chinese adults aged 90 years and older.Polypharmacy among nonagenarians/centenarians in rural China.Dynapenic obesity and lower extremity function in elderly adults.Disability associated with obesity, dynapenia and dynapenic-obesity in Chinese older adults.Prevalence of sarcopenia and associated factors in hospitalised older patients: A cross-sectional study.Metabolic syndrome and disability in Chinese nonagenarians and centenarians.The gamma gap predicts 4-year all-cause mortality among nonagenarians and centenarians.A sarcopenia screening test predicts mortality in hospitalized older adults.Chemical peels for acne vulgaris: a systematic review of randomised controlled trials.Body mass index and disability in Chinese nonagenarians and centenarians.G-395A polymorphism in the promoter region of the KLOTHO gene associates with frailty among the oldest-old.Applications of the new ESPEN definition of malnutrition and SARC-F in Chinese nursing home residentsPrevalence and Associated Factors of Sarcopenia in Nursing Home Residents: A Systematic Review and Meta-analysisValidation of the Chinese version of the Mini Sarcopenia Risk Assessment questionnaire in community-dwelling older adultsThe role of frailty in predicting mortality and readmission in older adults in acute care wards: a prospective studySarcopenia for predicting mortality among elderly nursing home residents: SARC-F versus SARC-CalFScreening Sarcopenia in Community-Dwelling Older Adults: SARC-F vs SARC-F Combined With Calf Circumference (SARC-CalF)The Prevalence of Sarcopenia in Chinese Elderly Nursing Home Residents: A Comparison of 4 Diagnostic CriteriaComparing Mini Sarcopenia Risk Assessment With SARC-F for Screening Sarcopenia in Community-Dwelling Older AdultsComparison of four sarcopenia screening tools in nursing home residentsSARC-F for sarcopenia screening in community-dwelling older adults: Are 3 items enough?A sarcopenia index based on serum creatinine and cystatin C cannot accurately detect either low muscle mass or sarcopenia in urban community-dwelling older peopleThe joint effects of frailty and telomere length for predicting mortality in older adults: the National Health and Nutrition Examination Survey 1999-2002Predictive validity of two frailty tools for mortality in Chinese nursing home residents: frailty index based on common laboratory tests (FI-Lab) versus FRAIL-NHLandscape of Sarcopenia Research (1989‒2018): A Bibliometric Analysis
P50
Q24202101-3DD84324-9CA4-4E9A-B2DD-5FF1A6E65094Q26471562-289761A0-A9DD-4DEE-9853-B9E9235307F6Q33784576-3716873A-C845-44C2-9FD9-94B917119A5EQ33826376-86E614CB-F975-4982-841B-E7393999B967Q35924524-8EF60B02-7844-4FA0-B9F0-CBFA0FAC50F4Q37219432-ADBBB2F3-BD61-406E-8E61-6595932EEC0EQ37696874-659468F9-3051-452C-B039-0393EB6E7EB7Q37734770-DB3466FD-DCAA-4C58-A1DC-50A1906685C1Q38127711-BB2820ED-3E41-4597-9A3B-E1DC2425D689Q38169324-75C82669-9280-4BC0-B851-611711861FF1Q38962367-96CA8008-8273-424A-8279-BC115D083107Q38999749-556598FF-D2EC-4A22-863E-0FBF5A6A6367Q40238589-9F4EB13F-B9C9-4E5E-8B7D-022D4E01BDD9Q40958312-078DAB21-00C9-42D8-BECB-3B124F41E0A2Q41075004-DF49320D-7D87-4A96-9E8F-CBC498D86A00Q41703293-8725ADCA-C326-4EE2-8CDB-1FEB277AB3D5Q44279406-2C1A6769-CEDD-4539-8DED-49257FDFC181Q44511145-95A3D2B2-0870-458D-8C51-3D4D3582B044Q45920107-C6246B6B-F510-47B3-9DD8-325E0FE057ECQ47556380-B5A58817-39FE-4F5B-A1FA-7783CDA55247Q48128450-F581E77E-8005-49C4-871D-118879A313A0Q48215170-01C73A13-929A-4599-A02B-D925D2473F1CQ49735267-C4040E25-57EF-4F0B-AF75-A8B57D9DC21BQ53282170-CD0D8947-4857-4CAF-B5DF-733A9C650CC8Q54520615-9EE77161-9CE5-4EE0-8E03-7E096E36B96CQ55169926-F276BF08-92EB-406A-9958-BDF8856A39F4Q57296208-2EE735F8-22B9-48D7-8796-095713431E00Q58610689-19859F95-CBFB-4427-85EB-B38B06260ACAQ58739432-82926651-0FD8-4CE1-927C-03EE8E05810CQ61800754-247845F4-FBE8-4DD6-802D-83A60D07620CQ64247303-E64A0790-FECD-49F6-9AA3-D96B032193AEQ87870578-06D354EA-166D-4A02-B500-3B31280EC0DBQ89067390-B120395B-81F5-486D-BB3E-175A9E0C2B80Q89125563-BF019F72-CCC7-4BD7-AD7A-86FCBE4AEA87Q90420592-B18E15F8-3592-4D35-8459-92618E786B91Q90470238-268DC41D-FCD6-4BA9-9C96-BEAD3191A896Q90698659-C3F62F6B-9C33-4499-9708-DEDDCECE066CQ90915592-63634977-5EC0-4669-8523-FF8B52F5807EQ91797157-2597CE72-3B78-4E4E-A24C-E0B19F5E38EBQ92586185-6D08183B-C1FF-44A2-BA6F-50E5695D3711
P50
description
onderzoeker
@nl
researcher, ORCID id # 0000-0002-1875-1692
@en
name
Ming
@ast
Ming
@en
Ming
@es
Ming
@nl
type
label
Ming
@ast
Ming
@en
Ming
@es
Ming
@nl
prefLabel
Ming
@ast
Ming
@en
Ming
@es
Ming
@nl
P1053
A-4973-2014
P106
P31
P3829
P3835
ming-yang59
P496
0000-0002-1875-1692